Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2025 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2025 Earnings Call Transcript October 29, 2025Vanda Pharmaceuticals Inc. misses on earnings expectations.
Vanda Pharmaceuticals Inc. (VNDA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 3,476,925 | $17,349,856 | +1% | 0.02% |
| 2. | Millennium Management Israel Englander | 3,250,836 | $16,221,672 | +5% | 0.01% |
| 3. | Tang Capital Management Kevin C. Tang | 2,353,307 | $11,743,002 | 0.45% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 909,300 | $4,537,407 | +13% | 0.01% |
| 5. | AQR Capital Management Cliff Asness | 668,466 | $3,335,646 | +393% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.15 | 10,000 | $41,500.00 | 2,335,731 | 2025-08-07 | Filing | |
| $4.39 | 481 | $2,111.59 | 2,325,731 | 2025-05-21 | Filing | |
| $4.40 | 9,519 | $41,883.60 | 2,325,250 | 2025-05-21 | Filing | |
| $4.22 | 20,000 | $84,472.00 | 2,315,731 | 2025-05-16 | Filing | |
| $5.01 | 5,000 | $25,050.00 | 2,295,731 | 2025-03-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.59 | 7,000 | $32,130.00 | 97,082 | 2025-06-13 | Filing | |
| $5.17 | 5,000 | $25,863.00 | 44,857 | 2024-11-14 | Filing | |
| $5.92 | 2,251 | $13,326.60 | 228,763 | 2024-07-29 | Filing | |
| $4.18 | 8,941 | $37,395.73 | 196,825 | 2024-03-05 | Filing | |
| $4.41 | 8,147 | $35,916.86 | 205,766 | 2024-03-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,918,305 | $44,502,342 | 0% | |
| 2. | 3,587,139 | $17,899,824 | 0% | |
| 3. | 2,563,969 | $12,793,562 | 0% | |
| 4. | 1,392,085 | $6,948,196 | 0% | |
| 5. | 1,271,079 | $6,342,684 | 0% |
News See All
22 Stocks on Jim Cramer’s Radar Recently
Cramer discussed that a number of major companies are struggling with limited supply, including Sandisk, Micron, and Boeing.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2025 Earnings Call Transcript
Operator: Good day, everyone, and thank you for standing by. My name is Argee, and I will be your conference operator today.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Quarter One 2025 Vanda Pharmaceuticals Incorporated Earnings Conference Call. I am Franz, and I will be the operator assisting you today.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2024 Earnings Call Transcript
Operator: Hello, and thank you for standing by. At this time, I would like to welcome you to the Q4 2024 Vanda Pharmaceuticals Inc. Earnings Conference Call.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2024 Earnings Call Transcript
Operator: Hello, and thank you for standing by. At this time, I would like to welcome you to the Q3 2024 Vanda Pharmaceuticals Inc. Earnings Conference Call.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Meg, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2024 Vanda Pharmaceuticals, Inc.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Hermine, and I will be your conference operator today. At this time, I would like to welcome everyone to Q1 2024 Vanda Pharmaceuticals, Inc.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Jeannie and I will be your conference operator today. At this time, I would like to welcome everyone to the Q4 2023 Vanda Pharmaceuticals Inc.
What Made Laughing Water Capital Sell Vanda Pharmaceuticals (VNDA)?
Laughing Water Capital, an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
